Dr. Elisa Scarselli (Nouscom CSO) invited speaker at EHTG European Hereditary Tumour Group 2023, Vilnius September 28 – October 1st

 In Presentations

PRESENTATION TITLE: Nous-209 genetic vaccine encoding shared cancer neoantigens has demonstrated safety and robust immunogenicity in patients with Microsatellite Instable Tumors and is under evaluation in Lynch syndrome carriers.

Please find the full report below:

Read more
Recent Posts
error: Content is protected !!!
Dr. Elisa Scarselli (CSO) invited speaker at Vaccines Europe 2023, Berlin September 13-15Presentations
Dr. Morena D’Alise (VP of Immunology) is presenting at the SITC Annual Meeting 2023, San Diego November 1-3Presentations